160 related articles for article (PubMed ID: 10572472)
1. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.
Franco E; Villa L; Rohan T; Ferenczy A; Petzl-Erler M; Matlashewski G
Rev Panam Salud Publica; 1999 Oct; 6(4):223-33. PubMed ID: 10572472
[TBL] [Abstract][Full Text] [Related]
2. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
[TBL] [Abstract][Full Text] [Related]
3. Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study.
Shaw E; Ramanakumar AV; El-Zein M; Silva FR; Galan L; Baggio ML; Villa LL; Franco EL;
BMC Infect Dis; 2016 Mar; 16():116. PubMed ID: 26956880
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
5. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia.
Villa LL; Sichero L; Rahal P; Caballero O; Ferenczy A; Rohan T; Franco EL
J Gen Virol; 2000 Dec; 81(Pt 12):2959-2968. PubMed ID: 11086127
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
7. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
[TBL] [Abstract][Full Text] [Related]
8. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.
Herrero R; Hildesheim A; Bratti C; Sherman ME; Hutchinson M; Morales J; Balmaceda I; Greenberg MD; Alfaro M; Burk RD; Wacholder S; Plummer M; Schiffman M
J Natl Cancer Inst; 2000 Mar; 92(6):464-74. PubMed ID: 10716964
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and invasive cervical cancer in Brazil.
Eluf-Neto J; Booth M; Muñoz N; Bosch FX; Meijer CJ; Walboomers JM
Br J Cancer; 1994 Jan; 69(1):114-9. PubMed ID: 8286192
[TBL] [Abstract][Full Text] [Related]
10. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil.
Villa LL; Franco EL
J Natl Cancer Inst; 1989 Mar; 81(5):332-40. PubMed ID: 2536815
[TBL] [Abstract][Full Text] [Related]
12. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
Ho GY; Burk RD; Klein S; Kadish AS; Chang CJ; Palan P; Basu J; Tachezy R; Lewis R; Romney S
J Natl Cancer Inst; 1995 Sep; 87(18):1365-71. PubMed ID: 7658497
[TBL] [Abstract][Full Text] [Related]
13. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer.
Chen HC; Schiffman M; Lin CY; Pan MH; You SL; Chuang LC; Hsieh CY; Liaw KL; Hsing AW; Chen CJ;
J Natl Cancer Inst; 2011 Sep; 103(18):1387-96. PubMed ID: 21900119
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
[TBL] [Abstract][Full Text] [Related]
15. [Human papillomavirus and cervical neoplasia].
Rosa MI; Medeiros LR; Rosa DD; Bozzeti MC; Silva FR; Silva BR
Cad Saude Publica; 2009 May; 25(5):953-64. PubMed ID: 19488480
[TBL] [Abstract][Full Text] [Related]
16. [Clearance, persistence and recurrence of HPV infection].
Denis F; Hanz S; Alain S
Gynecol Obstet Fertil; 2008 Apr; 36(4):430-40. PubMed ID: 18417407
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
18. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?
Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):799-805. PubMed ID: 9332762
[TBL] [Abstract][Full Text] [Related]
19. Persistent human papillomavirus infection and cervical neoplasia.
Ferenczy A; Franco E
Lancet Oncol; 2002 Jan; 3(1):11-6. PubMed ID: 11905599
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia.
Schiffman MH; Castle P
J Natl Cancer Inst; 2003 Mar; 95(6):E2. PubMed ID: 12644550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
